Literature DB >> 16736376

The effect of hepatitis C virus infection on health-related quality of life in prisoners.

Hla-Hla Thein1, Tony Butler, Murray Krahn, William Rawlinson, Michael H Levy, John M Kaldor, Gregory J Dore.   

Abstract

Hepatitis C virus (HCV) infection in prisoners represents an important public health problem. However, there is very little information about HCV-related health-related quality of life (HRQOL). We examined the effect of HCV antibody positivity, HCV viremia, and being a prisoner on prisoners'' HRQOL. Population-based health surveys incorporating HCV screening were conducted among prisoners at New South Wales (NSW), Australia, correctional centers in 1996 and 2001. HCV antibody and HCV RNA status were determined from venous blood sampling. HRQOL and mood status were assessed using the Short Form-36 (SF-36) Health Survey and Beck Depression Inventory (BDI). Comparison of HRQOL scores between HCV antibody negative, HCV antibody positive/non-viremic, and HCV antibody positive/viremic and assessment of temporal change in HRQOL between 1996 and 2001 within groups were made using ANCOVA adjusting for confounders. Factors associated with HRQOL were determined in linear regression models. Analyses between HCV antibody negative (n = 423), HCV positive/non-viremic (n = 89), and HCV positive/viremic (n = 178) prisoners found no measurable effect of HCV on HRQOL, including that attributable to HCV viremia. Compared to uninfected Australian population norms, prisoners had lower HRQOL irrespective of HCV status. The prevalence of 'moderate' to 'severe' depressive symptoms was greater in the HCV antibody positive/viremic group than the HCV antibody positive/non-viremic group or the HCV antibody negative group. Selected demographic factors (age), co-morbidity, severity of depressive symptoms and medical care utilization influenced HRQOL. There was evidence to support the effect of knowledge of HCV status on HRQOL. In conclusion, our findings contrast with previous studies in non-prisoner groups in which HCV infection appears to decrease overall HRQOL. Non-HCV factors may override HCV-specific HRQOL impairment in this population. Targeted management strategies are required to improve HRQOL of prisoners.

Entities:  

Mesh:

Year:  2006        PMID: 16736376      PMCID: PMC2527173          DOI: 10.1007/s11524-005-9015-4

Source DB:  PubMed          Journal:  J Urban Health        ISSN: 1099-3460            Impact factor:   3.671


  28 in total

1.  The effects of interferon alpha-2b in combination with ribavirin on health related quality of life and work productivity.

Authors:  J G McHutchison; J E Ware; M S Bayliss; S Pianko; J K Albrecht; S Cort; I Yang; M P Neary
Journal:  J Hepatol       Date:  2001-01       Impact factor: 25.083

Review 2.  Causes and consequences of comorbidity: a review.

Authors:  R Gijsen; N Hoeymans; F G Schellevis; D Ruwaard; W A Satariano; G A van den Bos
Journal:  J Clin Epidemiol       Date:  2001-07       Impact factor: 6.437

3.  Multiple chronic health problems are negatively associated with health related quality of life (HRQoL) irrespective of age.

Authors:  H Michelson; C Bolund; Y Brandberg
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

4.  Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease.

Authors:  Daniel M Forton; Howard C Thomas; Christine A Murphy; Joanna M Allsop; Graham R Foster; Janice Main; Keith A Wesnes; Simon D Taylor-Robinson
Journal:  Hepatology       Date:  2002-02       Impact factor: 17.425

5.  The impact of diagnosis of hepatitis C virus on quality of life.

Authors:  A J Rodger; D Jolley; S C Thompson; A Lanigan; N Crofts
Journal:  Hepatology       Date:  1999-11       Impact factor: 17.425

6.  Mental disorder in the New South Wales prisoner population.

Authors:  Tony Butler; Stephen Allnutt; David Cain; Dale Owens; Christine Muller
Journal:  Aust N Z J Psychiatry       Date:  2005-05       Impact factor: 5.744

7.  Comorbidities and quality of life in patients with interferon-refractory chronic hepatitis C.

Authors:  R J Fontana; C A Moyer; S Sonnad; N Sneed-Pee; J Walsh; S Klein; S Webster
Journal:  Am J Gastroenterol       Date:  2001-01       Impact factor: 10.864

8.  Comorbid illness is an important determinant of health-related quality of life in patients with chronic hepatitis C.

Authors:  K B Hussain; R J Fontana; C A Moyer; G L Su; N Sneed-Pee; A S Lok
Journal:  Am J Gastroenterol       Date:  2001-09       Impact factor: 10.864

9.  Evidence for a cerebral effect of the hepatitis C virus.

Authors:  D M Forton; J M Allsop; J Main; G R Foster; H C Thomas; S D Taylor-Robinson
Journal:  Lancet       Date:  2001-07-07       Impact factor: 79.321

10.  Emotional distress in chronic hepatitis C patients not receiving antiviral therapy.

Authors:  Robert J Fontana; Khozema B Hussain; Steven M Schwartz; Cheryl A Moyer; Grace L Su; Anna S F Lok
Journal:  J Hepatol       Date:  2002-03       Impact factor: 25.083

View more
  5 in total

Review 1.  Controversies in and challenges to our understanding of hepatitis C.

Authors:  Robert G Batey
Journal:  World J Gastroenterol       Date:  2007-08-21       Impact factor: 5.742

2.  Changes in health-related quality of life following imprisonment in 92 women in England: a three month follow-up study.

Authors:  Emma Plugge; Nick Douglas; Ray Fitzpatrick
Journal:  Int J Equity Health       Date:  2011-05-25

3.  Quality of Life and Social Functioning during Treatment of Recent Hepatitis C Infection: A Multi-Centre Prospective Cohort.

Authors:  Joseph S Doyle; Jason Grebely; Tim Spelman; Maryam Alavi; Gail V Matthews; Alexander J Thompson; Gregory J Dore; Margaret E Hellard
Journal:  PLoS One       Date:  2016-06-29       Impact factor: 3.240

4.  Persistent symptoms following SARS-CoV-2 infection amongst children and young people: A meta-analysis of controlled and uncontrolled studies.

Authors:  S A Behnood; R Shafran; S D Bennett; A X D Zhang; L L O'Mahoney; T J Stephenson; S N Ladhani; B L De Stavola; R M Viner; O V Swann
Journal:  J Infect       Date:  2021-11-20       Impact factor: 6.072

5.  Health-state utilities in a prisoner population: a cross-sectional survey.

Authors:  Christopher A K Y Chong; Sicong Li; Geoffrey C Nguyen; Andrew Sutton; Michael H Levy; Tony Butler; Murray D Krahn; Hla-Hla Thein
Journal:  Health Qual Life Outcomes       Date:  2009-08-28       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.